LANTUS INSULIN OVERDOSE: A CASE REPORT

被引:19
作者
Lu, Michael [1 ]
Charles, Pholaphat [1 ]
机构
[1] Univ Rochester, Med Ctr, Dept Emergency Med, Rochester, NY 14642 USA
关键词
insulin glargine; hypoglycemia; overdose; INTENTIONAL OVERDOSE; NPH INSULIN; GLARGINE; HYPOGLYCEMIA; MANAGEMENT; PHARMACOKINETICS; DURATION; PATIENT; ASPART;
D O I
10.1016/j.jemermed.2010.04.007
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: Insulin glargine is a relatively new medication in the treatment of diabetes mellitus, and there have only been six case reports of overdoses in the literature with this specific insulin. Objectives: We present a unique case of insulin glargine overdose that presented with persistent hypoglycemia and required prolonged in-hospital treatment. Case Report: A 51-year-old woman with insulin-dependent diabetes and a history of suicide attempts by medication overdose presented to the Emergency Department the morning after she had self-administered 2700 units of her insulin glargine in an attempted suicide. She was treated with continuous intravenous dextrose infusion with liberal oral intake, and continued to have recurrent hypoglycemic episodes 96 h into her hospital stay. She was discharged on hospital day 5 after psychiatric clearance without any permanent complications. Conclusions: A single massive overdose of insulin glargine can present with prolonged hypoglycemia. Emergency physicians should have a low threshold for initiating continuous dextrose infusions and admitting these patients for frequent blood glucose and serum electrolyte monitoring, preferably in an intensive care setting. (C) 2011 Elsevier Inc.
引用
收藏
页码:374 / 377
页数:4
相关论文
共 20 条
[1]   INSULIN OVERDOSE IN EIGHT PATIENTS - INSULIN PHARMACOKINETICS AND REVIEW OF THE LITERATURE [J].
AREM, R ;
ZOGHBI, W .
MEDICINE, 1985, 64 (05) :323-332
[2]   Intentional overdose with insulin glargine [J].
Ashawesh, Khaled ;
Padinjakara, Rayin N. Kulambil ;
Murthy, Narasimha P. ;
Nizar, Hisham ;
Anwar, Aresh .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (06) :534-534
[3]   Poisoning with insulin glargine [J].
Brvar, M ;
Mozina, M ;
Bunc, M .
CLINICAL TOXICOLOGY, 2005, 43 (03) :219-220
[4]   Prolonged glucose requirements after intentional glargine and aspart overdose [J].
Fromont, I. ;
Benhaim, D. ;
Ottomani, A. ;
Valero, R. ;
Molines, L. ;
Vialettes, B. .
DIABETES & METABOLISM, 2007, 33 (05) :390-392
[5]   LANTUS OVERDOSE: CASE PRESENTATION AND MANAGEMENT OPTIONS [J].
Fuller, Everett T. ;
Miller, Michael A. ;
Kaylor, David W. ;
Janke, Cliff .
JOURNAL OF EMERGENCY MEDICINE, 2009, 36 (01) :26-29
[6]   Insulin glargine [J].
Gillies, PS ;
Figgitt, DP ;
Lamb, HM .
DRUGS, 2000, 59 (02) :253-260
[7]   Time-action profile of the long-acting insulin analog insulin glargine (HOE901) in comparison with those of NPH insulin and placebo [J].
Heinemann, L ;
Linkeschova, R ;
Rave, K ;
Hompesch, B ;
Sedlak, M ;
Heise, T .
DIABETES CARE, 2000, 23 (05) :644-649
[8]   Acute hepatic steatosis complicating massive insulin overdose and excessive glucose administration [J].
Jolliet, P ;
Leverve, X ;
Pichard, C .
INTENSIVE CARE MEDICINE, 2001, 27 (01) :313-316
[9]   Unintentional overdose of insulin glargine [J].
Kuhn, Bryan ;
Cantrell, Lee .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2008, 65 (06) :508-508
[10]   Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro [J].
Lepore, M ;
Pampanelli, S ;
Fanelli, C ;
Porcellati, F ;
Bartocci, L ;
Di Vincenzo, A ;
Cordoni, C ;
Costa, E ;
Brunetti, P ;
Bolli, GB .
DIABETES, 2000, 49 (12) :2142-2148